Pharmaceutical Technology

AUGUST 12, 2022

Adoptive cell therapy (ACT) is a form of cancer treatment that involves the transfer of immune cells into a patient to help fight the disease, by eliminating cancer cells. By 2028, the market is expected to reach $25 billion, with a compound annual growth rate (CAGR) of 46.6%. billion in 2021 and is forecast to reach $2.4

Immunity 52

Immunity Immunization Chemotherapy Compounding 52

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. GlobalData’s analyst consensus forecast database estimates peak annual sales for ARV-110 of $325 million in 2028.

Dosage 59

Dosage Chemotherapy Compounding Immunity 59

Pharmaceutical Technology

MAY 26, 2023

This high compound annual growth rate of 23.6% was powered by the advent of immune-checkpoint inhibitors, added Chalk. These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028. GlobalData is the parent company of Pharmaceutical Technology.

Immunity 105

Immunity Immunization Vaccines Compounding 105

Express Pharma

APRIL 10, 2025

Additionally, we are expanding our regulatory approvals to enter international markets and are engaging with global health organisations to integrate needle-free technology into immunization programs, making injections safer and more accessible worldwide. billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16

Vaccines 82

Vaccines Hospitals Packaging Dosage 82